Active

V-Bio Ventures

General contacts

Investor type

Founded

2015

AUM

$205 M

Location

Ghent, East Flanders, Belgium

Investment Ticket

$1-5 m

Investment Stage

Seed Series A Series B

Region of investment

Europe

Investor profile last updated: 13 October, 2026

Profile

V-Bio Ventures is a Venture Capital firm focused on the life sciences sector, headquartered in Belgium. The firm was founded in 2015 by Christina Takke and Willem Broekaert, both of whom have extensive backgrounds in biotechnology and venture capital. V-Bio Ventures has a team that includes managing partners, partners, and venture partners with diverse expertise across various facets of the life sciences and financial sectors. Their unique approach lies in co-creating startups and investing in early to mid-stage companies with high growth potential by leveraging scientific innovation and deep industry networks.

The firm invests primarily in the therapeutics sector, focusing on drug discovery and development. They target early to mid-stage startups in Europe and are open to opportunities beyond. The firm manages €186 million across two funds, supported by a diverse investor base that includes financial institutions, governmental bodies, private family offices, and academic institutions. V-Bio Ventures has a preferred relationship with VIB, a premier life science research institute in Belgium, which aids in sourcing and developing venture opportunities.

Notable investments in V-Bio Ventures' portfolio showcase their strategic focus on innovative healthcare solutions. The firm has invested in companies that target drug discovery and development processes, aiming to bring impactful products to the market.

Industry

HealthTech MedTech Pharmaceuticals Healthcare Services Biotechnology

Contacts

Name

Title

Social Networks

Christina Takke Managing Partner

Managing Partner

c•••@•••

Shelley Margetson Managing Partner

Managing Partner

s•••@•••

Upgrade to see contacts

TqCWbmthpnl4z7s3 TqCWbmthpnl4z7s3

TqCWbmthpnl4z7s3

[email protected]

TqCWbmthpnl4z7s3 TqCWbmthpnl4z7s3

TqCWbmthpnl4z7s3

[email protected]

TqCWbmthpnl4z7s3 TqCWbmthpnl4z7s3

TqCWbmthpnl4z7s3

[email protected]

Investment-team contacts for V-Bio Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about V-Bio Ventures

Is V-Bio Ventures a venture capital or private equity firm?

V-Bio Ventures is a venture capital firm. It backs companies at Seed, Series A and Series B, writing tickets of $1-5 m.

Where is V-Bio Ventures located?

V-Bio Ventures is located in Ghent, East Flanders, Belgium.

When was V-Bio Ventures founded?

V-Bio Ventures was founded in 2015.

What sectors and industries does V-Bio Ventures invest in?

V-Bio Ventures invests in companies and startups in HealthTech, MedTech, Pharmaceuticals, Healthcare Services, Biotechnology.

What is V-Bio Ventures geographical focus of investments?

V-Bio Ventures invests in companies and startups in Europe.

At what stages of companies and startups does V-Bio Ventures typically invest in?

V-Bio Ventures invests in companies and startups at Seed, Series A, Series B.

What is the usual amount of V-Bio Ventures investment?

V-Bio Ventures usually invests $1-5 m on average.

What is the amount of assets of under management (AUM) for V-Bio Ventures?

V-Bio Ventures has around $205m assets under management.

What are the contacts of V-Bio Ventures?

V-Bio Ventures can be reached through its website v-bio.ventures and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for V-Bio Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access V-Bio Ventures data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query V-Bio Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the V-Bio Ventures profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 13 October, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.